PT Darya-Varia Laboratoria TbkISX:DVLA 74 Interest Coverage is 35,653.29 as of Mar. 2026, which is 1628% above its 10-year median of 2,062.69. GuruFocus rates ISX:DVLA with a GF Score™ of 74/100 and a GF Value™ of Rp1,842.26 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 686 Drug Manufacturers companies, PT Darya-Varia Laboratoria Tbk ranks better than 95.48% on this metric.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's
Operating Income
by its Interest Expense. PT Darya-Varia Laboratoria Tbk's
Operating Income
for the
three
months ended in Mar. 2026 was Rp68,882 Mil. PT Darya-Varia Laboratoria Tbk's Interest Expense for the
three
months ended in Mar. 2026 was Rp-2 Mil.
PT Darya-Varia Laboratoria Tbk's interest coverage for the quarter that ended in Mar. 2026 was 35,653.29.
The higher the ratio, the stronger the company's financial strength is.
Good Sign:
Ben Graham prefers companies' interest coverage to be at least 5. PT Darya-Varia Laboratoria Tbk has enough cash to cover all of its debt. Its financial situation is stable.
The historical rank and industry rank for PT Darya-Varia Laboratoria Tbk's Interest Coverage or its related term are showing as below:
ISX:DVLA'
s Interest Coverage Range Over the Past 10 Years
Min: 429.59 Med: 2062.69 Max: 7168.45
Current: 7168.45
ISX:DVLA's Interest Coverage is ranked better than 95.48% of 686
companies
in the Drug Manufacturers industry
Industry Median: 12.725
vs ISX:DVLA: 7168.45
Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.
Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .
PT Darya-Varia Laboratoria Tbk Interest Coverage Related Terms
PT Darya-Varia Laboratoria Tbk Interest Coverage Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
ISX:DVLA vs ZTS, UTHR, VTRS: Interest Coverage Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, PT Darya-Varia Laboratoria Tbk's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PT Darya-Varia Laboratoria Tbk Interest Coverage vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, PT Darya-Varia Laboratoria Tbk's Interest Coverage distribution charts can be found below:
* The bar in red indicates where PT Darya-Varia Laboratoria Tbk's Interest Coverage falls into.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PT Darya-Varia Laboratoria Tbk (ISX:DVLA) has a Interest Coverage of 35,653.29 as of Mar. 2026. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on PT Darya-Varia Laboratoria Tbk and its competitors. This is 1628% above median its historical median of 2,062.69. Over the past decade, PT Darya-Varia Laboratoria Tbk's Interest Coverage has ranged from 429.59 to 7,168.45. According to the industry distribution chart, PT Darya-Varia Laboratoria Tbk ranks #31 out of 686 companies in the Drug Manufacturers industry, placing it in the top 4.5%.
Is PT Darya-Varia Laboratoria Tbk's Interest Coverage too high?
PT Darya-Varia Laboratoria Tbk's current Interest Coverage of 35,653.29 is 1628% above median its 10-year median of 2,062.69. Over the past 10 years, this metric has ranged from a low of 429.59 to a high of 7,168.45. The Drug Manufacturers industry median Interest Coverage is 12.73. PT Darya-Varia Laboratoria Tbk's value of 35,653.29 is 280083% above this industry median. Based on the distribution chart, PT Darya-Varia Laboratoria Tbk ranks #31 out of 686 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, PT Darya-Varia Laboratoria Tbk has a GF Score™ of 74/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does PT Darya-Varia Laboratoria Tbk's Interest Coverage compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, PT Darya-Varia Laboratoria Tbk ranks #31 out of 686 companies for Interest Coverage. This places PT Darya-Varia Laboratoria Tbk in the top 5% of its industry — outperforming the majority of peers. The industry median Interest Coverage is 12.73. PT Darya-Varia Laboratoria Tbk's value of 35,653.29 is 280083% above this benchmark. Historically, PT Darya-Varia Laboratoria Tbk's own Interest Coverage has ranged from 429.59 to 7,168.45 over the past decade. While the company's 10-year median is 2,062.69 vs. the industry median of 12.73, PT Darya-Varia Laboratoria Tbk has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Drug Manufacturers company?
The median Interest Coverage among Drug Manufacturers companies is 12.73, based on 686 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. PT Darya-Varia Laboratoria Tbk's current Interest Coverage of 35,653.29 is 280083% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on PT Darya-Varia Laboratoria Tbk and its competitors. For the Drug Manufacturers industry, the median Interest Coverage is 12.73 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PT Darya-Varia Laboratoria Tbk's current Interest Coverage is 35,653.29, which is 1628% above median its own 10-year median of 2,062.69. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Darya-Varia Laboratoria Tbk stock overvalued right now?
Based on GuruFocus' analysis, PT Darya-Varia Laboratoria Tbk (ISX:DVLA) is currently considered Modestly Undervalued. The stock's GF Value™ is Rp1,842.26, compared to a current price of Rp1,510.00 — trading 18% below its estimated fair value. The current Interest Coverage is 35,653.29, which is 1628% above median its 10-year median of 2,062.69 and 280083% above the Drug Manufacturers industry median of 12.73. PT Darya-Varia Laboratoria Tbk's overall GF Score™ is 74/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For PT Darya-Varia Laboratoria Tbk (ISX:DVLA), the current Interest Coverage is 35,653.29 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is PT Darya-Varia Laboratoria Tbk (ISX:DVLA) Overvalued in 2026?
Based on GuruFocus' analysis, PT Darya-Varia Laboratoria Tbk stock appears to be undervalued.
The current stock price of Rp1,510.00 is trading 18% below its estimated GF Value™ of Rp1,842.26.
GuruFocus considers PT Darya-Varia Laboratoria Tbk to be Modestly Undervalued.
Key valuation signals for ISX:DVLA:
Interest Coverage: 35,653.29 (1628% above median its 10-year median of 2,062.69)
GF Value™: Rp1,842.26 vs. price of Rp1,510.00 (18% below fair value)
Industry Position: 280083% above the Drug Manufacturers median (#31 of 686)
No single metric tells the full story. See the ISX:DVLA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
PT Darya-Varia Laboratoria Tbk Business Description
PT Darya-Varia Laboratoria Tbk (Darya-Varia) is operating in the pharmaceutical industry. It is engaged in the manufacture and trade of pharmaceutical products, human, traditional medicines, pharmaceutical materials, raw materials for traditional medicines, inorganic base chemicals, organic base chemicals, equipment for surgery, medical and dental care, and equipment, orthopedic equipment, prosthetic, eyeglasses, laboratory and health equipment from glass, cosmetics, wholesaler of pharmaceutical, traditional medicine, chemical base materials, laboratory testing services, periodic inspection services, and many more activities. Its business segments include: prescription drugs; consumer health products, which derives key revenue; export and toll manufacturing services; and services.
74GF Score
Get the complete analysis for ISX:DVLA
Interest Coverage is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ISX:DVLA has been successfully added to your 
